Therefore, data from the GENIE-Project (Genomics Evidence Neoplasia Information Exchange) of the American Association for Cancer Research (AACR) showing that PIK3CA is the most frequent mutated gene in HR+/HER2-breast cancer patients, are very promising [6, 7]. This evidence concerns the gene PIK3CA and breast carcinoma.